Department of Anesthesiology, College of Physicians and Surgeons of Columbia University, New York, NY, USA.
Lab Invest. 2010 Mar;90(3):476-95. doi: 10.1038/labinvest.2009.143. Epub 2010 Jan 11.
Acute kidney injury (AKI) is frequent after liver ischemia reperfusion (IR) can potentiate liver injury and is often complicated by subsequent multiorgan dysfunction syndrome. AKI because of liver IR is characterized by early renal endothelial cell apoptosis and impaired vascular integrity with subsequent neutrophil infiltration, proximal tubule necrosis/inflammation, and filamentous (F) actin disintegration. We tested whether selective renal overexpression of human A(1) adenosine receptors (huA(1)AR) protects against both liver and kidney injury sustained after liver IR. Mice were subjected to liver IR or to sham surgery 48 h after unilateral intrarenal injection of lentivirus encoding enhanced green fluorescent protein (EGFP) or EGFP-huA(1)AR. Intrarenal lentiviral gene delivery caused a robust transgene expression in the injected kidney without significant expression in the contralateral kidney or in the liver. Mice injected with EGFP-huA(1)AR lentivirus were protected against hepatic IR-induced liver and kidney injury with reduced necrosis, inflammation, and apoptosis, and better preserved F-actin and vascular permeability compared with mice injected with EGFP lentivirus. Importantly, we show that removing the EGFP-huA(1)AR lentivirus-injected kidney before hepatic ischemia abolished both renal and hepatic protection after liver IR showing that the overexpression of huA(1)AR in the injected kidney has a crucial role in protecting the kidney and liver after liver IR. Therefore, our findings show that protecting the kidney reduces liver IR injury and selective overexpression of cytoprotective A(1)ARs in the kidney leads to protection of both liver and kidney after hepatic IR.
肝缺血再灌注(IR)后常发生急性肾损伤(AKI),可加重肝损伤,并常并发多器官功能障碍综合征。AKI 由于肝 IR 的特点是早期肾内皮细胞凋亡和血管完整性受损,随后中性粒细胞浸润、近端肾小管坏死/炎症和丝状(F)肌动蛋白解体。我们测试了选择性肾过度表达人 A(1)腺苷受体(huA(1)AR)是否可以预防肝 IR 后持续的肝和肾损伤。小鼠接受肝 IR 或单侧肾内注射慢病毒编码增强型绿色荧光蛋白(EGFP)或 EGFP-huA(1)AR 后的假手术 48 小时。肾内慢病毒基因传递导致注射肾中强大的转基因表达,而对对侧肾或肝中的表达无明显影响。与注射 EGFP 慢病毒的小鼠相比,注射 EGFP-huA(1)AR 慢病毒的小鼠对肝 IR 诱导的肝和肾损伤具有保护作用,其坏死、炎症和凋亡减少,F-肌动蛋白和血管通透性更好。重要的是,我们表明,在肝缺血前去除注射 EGFP-huA(1)AR 慢病毒的肾脏,可消除肝 IR 后肾和肝的保护作用,表明注射肾中 huA(1)AR 的过度表达在肝 IR 后保护肾脏和肝脏中起着至关重要的作用。因此,我们的研究结果表明,保护肾脏可以减轻肝 IR 损伤,选择性过度表达肾保护性 A(1)AR 可在肝 IR 后保护肝脏和肾脏。